Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000119 |
Acetylmuramyl-Alanyl-Isoglutamine |
[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of IL23A mRNA | affects expression | 16483693
|
D001104 |
Arbutin |
Arbutin results in decreased expression of IL23A mRNA | decreases expression | 17103032
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of IL23A mRNA | increases expression | 20064835
|
D047071 |
beta-Glucans |
beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|increases expression | 18490488
|
D047071 |
beta-Glucans |
beta-Glucans results in increased expression of IL23A mRNA | increases expression | 18490488
|
D047071 |
beta-Glucans |
IFNG protein inhibits the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|decreases reaction|increases expression | 18490488
|
D047071 |
beta-Glucans |
IFNG protein inhibits the reaction [beta-Glucans results in increased expression of IL23A mRNA] | decreases reaction|increases expression | 18490488
|
D047071 |
beta-Glucans |
R 848 promotes the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|increases expression|increases reaction | 18490488
|
D047071 |
beta-Glucans |
R 848 promotes the reaction [beta-Glucans results in increased expression of IL23A mRNA] | increases expression|increases reaction | 18490488
|
D004391 |
Dust |
Dust results in increased expression of IL23A mRNA | increases expression | 17805423
|
D005576 |
Forskolin |
Forskolin results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|increases expression | 15180965
|
D005576 |
Forskolin |
Forskolin results in increased expression of IL23A protein | increases expression | 15180965
|
C031927 |
hydroquinone |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL23A mRNA] | decreases reaction|increases expression | 17464197
|
D008070 |
Lipopolysaccharides |
[Lipopolysaccharides co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of IL23A mRNA | increases expression | 15516327 15860229
|
D008070 |
Lipopolysaccharides |
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL23A mRNA] | decreases reaction|increases expression | 17464197
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of IL23A mRNA | increases expression | 17464197
|
C508075 |
Pam(3)CSK(4) peptide |
[Acetylmuramyl-Alanyl-Isoglutamine co-treated with Pam(3)CSK(4) peptide co-treated with IFNG protein] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488
|
D010457 |
Peptidoglycan |
Peptidoglycan results in increased expression of IL23A mRNA | increases expression | 15860229
|
D015240 |
Phorbol 12,13-Dibutyrate |
Phorbol 12,13-Dibutyrate results in increased expression of IL23A mRNA | increases expression | 15516327
|
D015232 |
Dinoprostone |
CSF2 protein promotes the reaction [Dinoprostone results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|increases expression|increases reaction | 15180965
|
D015232 |
Dinoprostone |
Dinoprostone results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|increases expression | 15180965
|
D015232 |
Dinoprostone |
Dinoprostone results in increased expression of IL23A protein | increases expression | 15180965
|
C402365 |
R 848 |
IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488
|
C402365 |
R 848 |
[Lipopolysaccharides co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488
|
C402365 |
R 848 |
R 848 promotes the reaction [beta-Glucans results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|increases expression|increases reaction | 18490488
|
C402365 |
R 848 |
R 848 promotes the reaction [beta-Glucans results in increased expression of IL23A mRNA] | increases expression|increases reaction | 18490488
|
C402365 |
R 848 |
[Zymosan co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488
|
C045282 |
roquinimex |
roquinimex results in decreased expression of IL23A mRNA | decreases expression | 15270847
|
C121329 |
sanglifehrin A |
sanglifehrin A results in decreased expression of IL23A mRNA | decreases expression | 12847216
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of IL23A mRNA | increases expression | 18175754
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [C5 protein results in decreased expression of IL23A mRNA] | decreases expression|decreases reaction | 16116186
|
D015054 |
Zymosan |
IFNG protein promotes the reaction [[Zymosan co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|affects cotreatment|increases expression|increases reaction | 18490488
|
D015054 |
Zymosan |
IFNG protein promotes the reaction [Zymosan results in increased expression of [IL12B protein binds to IL23A protein]] | affects binding|increases expression|increases reaction | 18490488
|
D015054 |
Zymosan |
[Zymosan co-treated with R 848] results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|affects cotreatment|increases expression | 18490488
|
D015054 |
Zymosan |
Zymosan results in increased expression of [IL12B protein binds to IL23A protein] | affects binding|increases expression | 18490488
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.50 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.97 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
1.97 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.61 | 6695378 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Dinoprostone |
4.97 | 17942926 |
MESH:D000740 |
Anemia |
|
Zymosan |
4.49 | 18664788 |
MESH:D001014 |
Aortic Aneurysm |
|
Dinoprostone |
5.54 | 10231640 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
11.78 | 19183758 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Dinoprostone |
11.78 | 10388637 |
MESH:D001169 |
Arthritis, Experimental |
|
Zymosan |
4.08 | 15142272 15188379 16872482 15944321 17659584 |
MESH:D001477 |
Bartter Syndrome |
|
Dinoprostone |
5.68 | 15976003 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.05 | 20146248 17474063 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
2.03 | 20419170 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Dinoprostone |
4.17 | 16192471 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.69 | 15894690 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.72 | 16285004 |
MESH:D003967 |
Diarrhea |
|
Dinoprostone |
4.49 | 11488427 10446763 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.27 | 15131321 |
MESH:D004487 |
Edema |
|
Zymosan |
3.93 | 7907874 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.33 | 15328337 15821434 17637181 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
1.99 | 16530937 |
MESH:D005334 |
Fever |
|
Dinoprostone |
9.43 | 16997862 11852909 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
9.43 | 9205823 11852909 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
2.62 | 20471113 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.32 | 16366002 |
MESH:D006505 |
Hepatitis |
|
Zymosan |
4.63 | 19110552 |
MESH:D006930 |
Hyperalgesia |
|
Dinoprostone |
4.47 | 16793879 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
5.56 | 17963957 17237260 9205823 12878042 17255318 |
MESH:D007249 |
Inflammation |
|
Zymosan |
5.56 | 11289658 8014878 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.23 | 14714311 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.57 | 17255318 |
MESH:D043183 |
Irritable Bowel Syndrome |
|
Zymosan |
5.78 | 17553498 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.64 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dinoprostone |
3.14 | 15816358 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
3.14 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Dinoprostone |
3.44 | 15816358 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.02 | 21137059 20195826 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.94 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.56 | 20464547 6695378 18816296 18520028 18569708 17053015 20869020 20135361 20064080 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.00 | 14737004 |
MESH:D020326 |
Migraine without Aura |
|
Dinoprostone |
5.20 | 11304026 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.14 | 16381670 |
MESH:D009102 |
Multiple Organ Failure |
|
Zymosan |
5.14 | 15834315 10479408 10890648 18160304 15213630 12130978 12879239 15241586 17724436 15259001 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.14 | 11141357 |
MESH:D010005 |
Osteoarthropathy, Secondary Hypertrophic |
|
Dinoprostone |
6.42 | 18500342 |
MESH:D010538 |
Peritonitis |
|
Zymosan |
4.82 | 19088179 15979727 18557954 14761945 17826846 11985352 15259001 18760300 19641140 18977430 17371808 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.49 | 12224865 11605937 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
3.24 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.24 | 18760546 |
MESH:D011565 |
Psoriasis |
marker/mechanism |
|
| 20953190 19169254 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.69 | 10835634 |
MESH:D018805 |
Sepsis |
|
Zymosan |
4.59 | 11441115 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
2.34 | 19755658 10029692 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
4.10 | 15821434 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.15 | 17053015 |
MESH:D014605 |
Uveitis |
|
Zymosan |
5.34 | 11006244 |